| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK050141-13
|
|
Pathologic Mechanisms of Polycystic Kidney Disease
|
WANDINGER-NESS, ANGELA
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$293,807
|
|
Polycystic Kidney Disease
|
NIDDK
|
5F32DK075270-02
|
|
A new gene family as modifiers of polycystin signaling
|
MILLER, RENEE
|
UNIVERSITY OF ROCHESTER
|
NY
|
$48,796
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK042921-16
|
|
Regulation of kidney-Specific Gene Expression
|
IGARASHI, PETER
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$306,265
|
|
Polycystic Kidney Disease
|
NIDDK
|
5F31DK077578-02
|
|
Characterization of polyductin family proteins
|
SAMAROO, TIFFANY
|
YALE UNIVERSITY
|
CT
|
$26,272
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK066370-05
|
|
Analysis of Genetic Modifiers of PKD in the Mouse
|
BEIER, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$348,321
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK066366-05
|
|
IFN gamma and other modifiers of kidney disease in TSC
|
DABORA, SANDRA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$255,476
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK053357-11
|
|
Molecular pathophysiology of Pkd2 mutations
|
ZHOU, JING
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$349,767
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK059597-07
|
|
Characterizing the Funtion of Fibbrocystin and Fibbrocystin-L
|
HARRIS, PETER
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$297,332
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK069274-04
|
|
Function of NPHP6 a novel gene for Senior-Loken syndrome
|
HILDEBRANDT, FRIEDHELM
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$327,374
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK065056-05
|
|
Analysis of ARPKD by Targeted Manipulation of Pkhd1
|
WARD, CHRISTOPHER
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$271,378
|
|
Polycystic Kidney Disease
|
NIDDK
|
5K25DK077302-02
|
|
Time resolved studies of transport in renal epithelial cells
|
HUA, ZONGLU
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$176,258
|
|
Polycystic Kidney Disease
|
NIDDK
|
5U01DK056943-08
|
|
Kansas Polycystic Kidney Imaging Program (CRISPII)
|
GRANTHAM, JARED
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$320,568
|
|
Polycystic Kidney Disease
|
NIDDK
|
5U01DK056957-08
|
|
Polycystic Kidney Disease: Innovative Imaging to Assess Progression (PCC)
|
TORRES, VICENTE
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$369,513
|
|
Polycystic Kidney Disease
|
NIDDK
|
5U01DK056956-08
|
|
"The Early Collaborative Clinical Studies in PKD: The C*
|
CHAPMAN, ARLENE
|
EMORY UNIVERSITY
|
GA
|
$337,438
|
|
Polycystic Kidney Disease
|
NIDDK
|
5U01DK056961-09
|
|
Data Coordinating and Image Analysis for CRISP-II
|
BAE, KYONGTAE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$428,981
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK040703-18
|
|
Molecular Pathology in Polycystic Kidney Disease
|
ZHOU, JING
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$341,380
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK069605-04
|
|
Crumbs3 in epithelial polarity and ciliogenesis
|
MARGOLIS, BENJAMIN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$312,775
|
|
Polycystic Kidney Disease
|
NIDDK
|
5F32DK076343-02
|
|
Regulation of Polycystin-2 Trafficking
|
YOUKER, ROBERT
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$49,646
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK067339-03
|
|
Pathogenic Mechanism of Polycystic Kidney Disease
|
CHEN, YUMAY
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$227,846
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK071073-04
|
|
Regulation of Signaling of PKD2 Cation Channel in Sperm
|
LU, XIANGYI
|
WAYNE STATE UNIVERSITY
|
MI
|
$293,586
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK051041-11
|
|
Genetics of Autosomal Dominant Polycystic Liver Disease
|
SOMLO, STEFAN
|
YALE UNIVERSITY
|
CT
|
$458,671
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK067565-05
|
|
Pathogenesis of PKD in Mice Lacking Renal Cilia
|
IGARASHI, PETER
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$340,648
|
|
Polycystic Kidney Disease
|
NICHD
|
2R01HD042601-06
|
|
Molecular Genetics of BBS
|
KATSANIS, NICHOLAS
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$432,472
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK067569-05
|
|
Jade-1 in cystic renal disease
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
MA
|
$296,216
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK051259-13
|
|
Molecular Genetics of Human ARPKD
|
GERMINO, GREGORY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$407,798
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK044863-15
|
|
Novel treatments for polycystic kidney disease
|
TORRES, VICENTE
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$211,251
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK068581-03
|
|
Pathogenesis of wpk-induced Renal and Cerebral Disease
|
GATTONE, VINCENT
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$263,674
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK051052-12
|
|
Mechanisms of Renal Tumorigenesis in Tuberous Sclerosis
|
HENSKE, ELIZABETH
|
FOX CHASE CANCER CENTER
|
PA
|
$308,251
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK024031-30
|
|
Pathobiology of Hepatic Epithelia
|
LARUSSO, NICHOLAS
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$503,420
|
|
Polycystic Kidney Disease
|
NIDDK
|
5K08DK062172-05
|
|
Regulation of Transepithelial Transport in PKD
|
ROHATGI, RAJEEV
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$127,685
|
|
Polycystic Kidney Disease
|
NIDDK
|
1K01DK075652-01A2
|
|
The role of the primary cilium in glomerular podocyte cells
|
KOLB, ROBERT
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$130,275
|
|
Polycystic Kidney Disease
|
NIGMS
|
5R01GM049760-15
|
|
Impact of naturally occurring osmolytes on protein structure and energetics
|
ROSGEN, JORG
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$310,193
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK068306-05
|
|
Identification of new genes causing nephronophthisis
|
HILDEBRANDT, FRIEDHELM
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$334,100
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK076017-03
|
|
PKD1-Fibrillin Interactions and TFG-b Signaling Pathways
|
WATNICK, TERRY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$292,610
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK074746-03
|
|
A Model for Nephronophthisis in Caenorhabditis elegans
|
BARR, MAUREEN
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$206,496
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK053093-11
|
|
Genetic analysis of zebrafish kidney development
|
DRUMMOND, IAIN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$351,575
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK058816-08
|
|
ADPKD: Disease Spectrum & Genotype-Phenotype Correlations
|
HARRIS, PETER
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$290,660
|
|
Polycystic Kidney Disease
|
NIDDK
|
5F32DK076443-02
|
|
Roles of TSC1 TDC2 and Rheb in renal cyst pathogenesis
|
HARTMAN, TIFFINEY
|
FOX CHASE CANCER CENTER
|
PA
|
$50,428
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK078209-02
|
|
Polycystin2 function in zebrafish and medaka
|
OBARA, TOMOKO
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$264,968
|
|
Polycystic Kidney Disease
|
NIDDK
|
7K08DK071108-03
|
|
Functional characterization of the novel protein nephrocystin-5
|
O'TOOLE, JOHN
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$130,870
|
|
Polycystic Kidney Disease
|
NINDS
|
5R37NS031535-15
|
|
Tuberous Sclerosis: Mutations and Murine Models
|
KWIATKOWSKI, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$338,848
|
|
Polycystic Kidney Disease
|
NIDDK
|
5U01DK062402-07
|
|
Clinical Trial to Slow the Progression of ADPKD
|
SCHRIER, ROBERT
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$727,054
|
|
Polycystic Kidney Disease
|
NIDDK
|
5U01DK062411-07
|
|
Polycystic Kidney Disease Clinical Trials Network
|
PERRONE, RONALD
|
TUFTS MEDICAL CENTER
|
MA
|
$866,183
|
|
Polycystic Kidney Disease
|
NIDDK
|
5U01DK062410-07
|
|
Controlled Trial of Renin Angiotensin Blockade in ADPKD
|
TORRES, VICENTE
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$880,697
|
|
Polycystic Kidney Disease
|
NIDDK
|
5U01DK062408-07
|
|
Polycystic Kidney Disease Clinical Trials Network
|
CHAPMAN, ARLENE
|
EMORY UNIVERSITY
|
GA
|
$526,066
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK069528-04
|
|
Sco, A Zebrafish Model Links Cilia and Kidney Cysts
|
SUN, ZHAOXIA
|
YALE UNIVERSITY
|
CT
|
$357,028
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK037274-23
|
|
Role of PACS proteins in polycystin-2 trafficking and ADPKD
|
THOMAS, GARY
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$326,060
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK069909-04
|
|
The Exocyst in Synthesis, Cystogenesis and Tubulogenesis
|
LIPSCHUTZ, JOSHUA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$240,017
|
|
Polycystic Kidney Disease
|
NIGMS
|
5R01GM060992-08
|
|
Intraflagellar Transport Proteins in Mice
|
PAZOUR, GREGORY
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$349,467
|
|
Polycystic Kidney Disease
|
NICHD
|
5R01HD036404-09
|
|
Mutagenesis and Murine Embyonic Development
|
BEIER, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$299,881
|
|
Polycystic Kidney Disease
|
NIDCD
|
5R21DC008967-02
|
|
The in vivo roles of PKD1L3 and PKD2L1 in sour taste detection
|
MATSUNAMI, HIROAKI
|
DUKE UNIVERSITY
|
NC
|
$230,958
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK055534-09
|
|
Cystin, a lipid raft and cilia-associated protein in PKD
|
GUAY-WOODFORD, LISA
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$316,629
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK059418-08
|
|
Polycystins and cilia in C. elegans
|
BARR, MAUREEN
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$284,996
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R37DK051050-13
|
|
Mouse model of polycystic kidney disease
|
ZHOU, JING
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$380,175
|
|
Polycystic Kidney Disease
|
NIDDK
|
5K08DK069316-04
|
|
ZEBRAFISH APPLICATIONS IN THE STUDY OF ADPKD
|
PARIKH, SAMIR
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$129,979
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK077149-02
|
|
Role of Na, K-ATPase beta isoforms in pump sorting and epithelial integrity
|
VAGIN, OLGA
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
CA
|
$181,952
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK071090-04
|
|
Molecular Genetics and Pathogenesis of ARPKD
|
WU, GUANQING
|
VANDERBILT UNIVERSITY
|
TN
|
$292,401
|
|
Polycystic Kidney Disease
|
NIGMS
|
5R37GM030626-28
|
|
Flagellar Motility and Assemlby
|
WITMAN, GEORGE
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$539,376
|
|
Polycystic Kidney Disease
|
NIDDK
|
5K23DK067303-05
|
|
Novel Cardiac Risk Factors & Endothelial Function in CKD
|
MENON, VANDANA
|
TUFTS MEDICAL CENTER
|
MA
|
$156,970
|
|
Polycystic Kidney Disease
|
NIDDK
|
2R01DK054740-09A1
|
|
Pax2 interacting proteins in Development and Disease
|
DRESSLER, GREGORY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$318,580
|
|
Polycystic Kidney Disease
|
NIDDK
|
2R01DK062338-07A1
|
|
STAT Regulation by Polycystin-1
|
WEIMBS, THOMAS
|
UNIVERSITY OF CALIFORNIA SANTA BARBARA
|
CA
|
$321,937
|
|
Polycystic Kidney Disease
|
NIDDK
|
1R01DK079005-01A1
|
|
Epithelial Angiogenic Signaling in Polycystic Diseases of the Liver
|
STRAZZABOSCO, MARIO
|
YALE UNIVERSITY
|
CT
|
$330,667
|
|
Polycystic Kidney Disease
|
NIDDK
|
2R01DK065655-05A1
|
|
Cilia and Cystic Kidney Disease
|
YODER, BRADLEY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$349,869
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK078043-02
|
|
Regulation of the mTOR pathway in polycystic kidney disease
|
WEIMBS, THOMAS
|
UNIVERSITY OF CALIFORNIA SANTA BARBARA
|
CA
|
$269,204
|
|
Polycystic Kidney Disease
|
NIDDK
|
5K08DK076733-03
|
|
Human Uremic Persistent Hyperparathyroidism: Functional and Molecular Aspects
|
EGBUNA, OGO
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$134,730
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK075972-02
|
|
The Role of Basa Bodies in Wnt Signaling
|
KATSANIS, NICHOLAS
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$329,476
|
|
Polycystic Kidney Disease
|
NIDDK
|
5F32DK079541-02
|
|
Novel Wnt effectors in renal cystic disease
|
DAVIS, ERICA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$49,646
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK045881-14
|
|
Regulation of CFTR Trafficking
|
STANTON, BRUCE
|
DARTMOUTH COLLEGE
|
NH
|
$334,309
|
|
Polycystic Kidney Disease
|
NIDDK
|
5K01DK067191-05
|
|
THE ROLE OF VEGF ON PDPKD DISEASE PROGRESSION
|
TAO, YUNXIA
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
TX
|
$124,818
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R37DK048006-15
|
|
Novel Approach to the Molecular Genetics of PKD1
|
GERMINO, GREGORY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$495,327
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK073394-03
|
|
The Nano-mechanics of Polycystin-1
|
OBERHAUSER, ANDRES
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$251,454
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P30DK079328-02
|
|
UT Southwestern O'Brien Kidney Research Core Center
|
IGARASHI, PETER
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$860,168
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK059599-07
|
|
Regulation of calcium signaling by the PKD2 gene product
|
TSIOKAS, LEONIDAS
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$215,355
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK058793-08
|
|
Effect of Statin Therapy on Disease Progression in Children with ADPKD
|
SCHRIER, ROBERT
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$552,450
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R21DK079028-02
|
|
The Role of the Calcium Activated Potassium Channel, KCa3.1, in the Pathogenesis
|
SKOLNIK, EDWARD
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$166,069
|
|
Polycystic Kidney Disease
|
NIDDK
|
1F32DK081262-01
|
|
Pre-clinical Testing of GSK3 Inhibitors in ADPKD
|
BARASH, IRINA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$59,702
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK075999-02
|
|
Pathogenesis of ADPKD-role of the transcriptional modulator TAZ
|
ARNAOUT, M. AMIN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$280,656
|
|
Polycystic Kidney Disease
|
NIGMS
|
5R01GM060448-08
|
|
Regulation of calcium-activated chloride channels
|
HARTZELL, H
|
EMORY UNIVERSITY
|
GA
|
$304,650
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK067343-04
|
|
Ion Transport Dysregulation in Cilium-deficient ARPKD
|
BEVENSEE, MARK
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$249,445
|
|
Polycystic Kidney Disease
|
NIGMS
|
5R01GM034437-20
|
|
Regulation of Flagellar Assembly in Chlamydomonas
|
LEFEBVRE, PAUL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$318,392
|
|
Polycystic Kidney Disease
|
NIDDK
|
5R01DK074835-02
|
|
Mammalian target of rapamycin (mTOR) signaling in polycystic kidney disease (PKD)
|
EDELSTEIN, CHARLES
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$296,368
|
|
Polycystic Kidney Disease
|
NIDDK
|
1R01DK081355-01
|
|
LIVE-CELL IMAGING OF CFTR OLIGOMERIZATION, TRAFFICKING AND INTERACTIONS
|
HAGGIE, PETER
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$309,000
|
|
Polycystic Kidney Disease
|
NIDDK
|
1K08DK081668-01
|
|
The Role of p120 Catenin in Metanephric Kidney Development
|
MARCIANO, DENISE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$140,724
|
|
Polycystic Kidney Disease
|
NIDDK
|
1R01DK078231-01A2
|
|
Role of polycystin-1 in centrosome duplication and cell cycle control
|
GUSELLA, GABRIELE LUCA
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$254,250
|
|
Polycystic Kidney Disease
|
NIDDK
|
2R01DK032753-25A1
|
|
Mechanisms of Transport in Proximal and Distal Tubules
|
GUGGINO, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$348,500
|
|
Polycystic Kidney Disease
|
NIDDK
|
1R01DK080640-01A1
|
|
The roles of primary cilia in cardiovascular system
|
NAULI, SURYA
|
UNIVERSITY OF TOLEDO
|
OH
|
$302,260
|
|
Polycystic Kidney Disease
|
NIDDK
|
1K01DK080179-01A1
|
|
Polycystin-1 Regulation of Galpha 12 and Integrins in Polycystic Kidney Disease
|
KONG, TIANQING
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$127,730
|
|
Polycystic Kidney Disease
|
NIDDK
|
1K01DK078741-01A1
|
|
Fleer: Functional study in regulation of vertebrate cilia tublin modification
|
PATHAK, NARENDRA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$136,625
|
|
Polycystic Kidney Disease
|
NIDDK
|
1R13DK082059-01
|
|
Polycystic Kidney Disease: Basic, Translational, and Clinical Science
|
BACALLAO, ROBERT
|
FEDERATION OF AMER SOC FOR EXPER BIOLOGY
|
MD
|
$5,000
|
|
Polycystic Kidney Disease
|
OD
|
1R13DK082059-01
|
|
Polycystic Kidney Disease: Basic, Translational, and Clinical Science
|
BACALLAO, ROBERT
|
FEDERATION OF AMER SOC FOR EXPER BIOLOGY
|
MD
|
$25,000
|
|
Polycystic Kidney Disease
|
NIDDK
|
1F32DK080576-01A1
|
|
Regulation of a cell volume sensitive CIC anion channel by Ste20 kinase signaling
|
FALIN, REBECCA
|
VANDERBILT UNIVERSITY
|
TN
|
$46,826
|
|
Polycystic Kidney Disease
|
NIDDK
|
1F32DK082145-01
|
|
Non-canonical Wnt Signals in Kidney Tubulogenesis
|
MILLER, RACHEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$46,826
|
|
Polycystic Kidney Disease
|
NIDCD
|
1F31DC009393-01A1
|
|
The Role of Pkd1 in Hair Cell Mechanotransduction Channels
|
STEIGELMAN, KATHERINE
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$28,690
|
|
Polycystic Kidney Disease
|
NIDDK
|
1U01DK082230-01
|
|
Data Coordinating Center for the HALT-Polycystic Kidney Disease Trials
|
BOST, JAMES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$1,000,000
|
|
Polycystic Kidney Disease
|
NIDDK
|
2R01DK062199-06A1
|
|
The Proteolytic Cleavage of Polycystin-1: How and Why
|
QIAN, FENG
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$348,500
|
|
Polycystic Kidney Disease
|
NIDDK
|
1F32DK083213-01
|
|
Mechanism of Liver Fibrosis and TGF-beta Signaling in Congenital Hepatic Fibrosis
|
WEN, JESSICA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$52,898
|
|
Polycystic Kidney Disease
|
NIDDK
|
3R01DK040703-18S1
|
|
Molecular Pathology in Polycystic Kidney Disease
|
ZHOU, JING
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$12,600
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK057328-10
|
0006
|
BIOCHEMISTRY AND CELL BIOLOGY OF POLYCYSTINS
|
SOMLO, STEFAN
|
YALE UNIVERSITY
|
CT
|
$212,644
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK057328-10
|
0007
|
POLYCYSTIN-1 TAIL CLEAVAGE: A NOVEL PKD SIGNALING PATHWAY
|
CAPLAN, MICHAEL
|
YALE UNIVERSITY
|
CT
|
$187,602
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK057328-10
|
0008
|
GENETIC ANALYSIS OF EARLY DEVELOPMENT AND DISEASES IN ZEBRAFISH
|
SUN, ZHAOXIA
|
YALE UNIVERSITY
|
CT
|
$174,827
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK057328-10
|
0010
|
FUNCTION AND REGULATION OF POLYCYSTIN-2
|
EHRLICH, BARBARA
|
YALE UNIVERSITY
|
CT
|
$171,319
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK057328-10
|
9003
|
CORE--MOUSE AND CELL LINE
|
SOMLO, STEFAN
|
YALE UNIVERSITY
|
CT
|
$135,257
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P30DK074038-04
|
9001
|
CORE--ARPKD CLINICAL AND GENETIC RESOURCE
|
GUAY-WOODFORD, LISA
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$170,489
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P30DK074038-04
|
9002
|
CORE--ENGINEERED MOUSE RESOURCE
|
YODER, BRADLEY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$312,066
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P30DK074038-04
|
9003
|
CORE--CELL PHYSIOLOGY RESOURCE
|
BELL, PHILLIP
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$195,033
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P30DK074038-04
|
9005
|
CORE--PROTEOMICS RESOURCE
|
KIM, HELEN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$147,843
|
|
Polycystic Kidney Disease
|
NIDDK
|
3U01DK062401-07S1
|
|
Data Coordinating Center for PKD Treatment Network
|
MILLER, J.
|
WASHINGTON UNIVERSITY
|
MO
|
$539,347
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK074030-04
|
0001
|
G PROTEIN SIGNALING IN POLYCYSTIC KIDNEY DISEASE
|
DENKER, BRADLEY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$94,789
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK074030-04
|
0002
|
INTEGRIN AND CADHERIN IN POLYCYSTIC KIDNEY DISEASE
|
KREIDBERG, JORDAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$226,201
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK074030-04
|
0003
|
CELL BIOLOGY OF POLYCYSTIC KIDNEY DISEASE PROTEINS
|
ZHOU, JING
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$364,550
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK074030-04
|
0005
|
Polycystin channels and calcium
|
ZHOU, JING
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$63,377
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK074030-04
|
0006
|
Kidney Injury Molecule-1 in ADPKD
|
ZHOU, JING
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$63,377
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK074030-04
|
9001
|
CORE--IMAGING
|
SHAH, JAGESH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$86,238
|
|
Polycystic Kidney Disease
|
NCRR
|
5M01RR023940-02
|
8464
|
CLINICAL TRIAL: HALT PKD
|
WINKLHOFER, FRANZ
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$258,104
|
|
Polycystic Kidney Disease
|
NCRR
|
5M01RR023940-02
|
8476
|
RENAL IMAGING IN ADPKD
|
GRANTHAM, JARED
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$65,992
|
|
Polycystic Kidney Disease
|
NCRR
|
5M01RR001032-33
|
5126
|
CLINICAL TRIAL: HALT-PKD
|
STEINMAN, THEODORE
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$9,638
|
|
Polycystic Kidney Disease
|
NCRR
|
5M01RR000051-47
|
5724
|
AGGRSSV RENIN-ANGIOTNSN-ALDOSTRN AXIS BLCKD IN PREVENT/SLOWING RENAL FNCTN DCLIN
|
SCHRIER, ROBERT
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$12,893
|
|
Polycystic Kidney Disease
|
NCRR
|
5P20RR015569-09
|
6068
|
AR COBRE: PROTEIN INTERACTION WITH THE EXTRACELLULAR MATRIX
|
SAKON, JOSHUA
|
UNIVERSITY OF ARKANSAS AT FAYETTEVILLE
|
AR
|
$253,357
|
|
Polycystic Kidney Disease
|
NCRR
|
5P20RR017686-07
|
7054
|
REGULATION OF NA TRANSPORT FUNCTION BY CFTR IN THYROID EPITHELIAL CELLS
|
FONG, PEYING
|
KANSAS STATE UNIVERSITY
|
KS
|
$164,643
|
|
Polycystic Kidney Disease
|
NCRR
|
2P41RR001646-26
|
7433
|
STRUCTURAL STUDIES ON TYROSINE KINASES AND POLYCYSTIN-1 AND -2
|
BOGGON, TITUS
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$12,177
|
|
Polycystic Kidney Disease
|
NCRR
|
5P41RR011823-13
|
5920
|
IDENTIFICATION OF MAMMALIAN INTRAFLAGELLAR TRANSPORT COMPLEXES FOR PRIMARY CILIA
|
SHAH, JAGESH
|
UNIVERSITY OF WASHINGTON
|
WA
|
$819
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK057301-10
|
0003
|
POLYCYSTIN-1 MEDIATED CALCIUM AND cAMP SIGNALING
|
CALVET, JAMES
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$228,447
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK057301-10
|
0006
|
CALCIUM REGULATION OF cAMP-DEPENDENT PROLIFERATION
|
WALLACE, DARREN
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$228,447
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK057301-10
|
0007
|
ROLE OF OXIDANT STRESS IN PROGRESSION OF PKD
|
MASER, ROBIN
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$228,448
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK057301-10
|
0008
|
CUX-1 AND CELL CYCLE REGULATION IN PKD
|
VANDEN HEUVEL, GREGORY
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$228,448
|
|
Polycystic Kidney Disease
|
NIDDK
|
5P50DK057301-10
|
9001
|
CORE--BIOMATERIALS
|
WALLACE, DARREN
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$124,612
|
|
Polycystic Kidney Disease
|
NIEHS
|
1Z01ES100485-07
|
|
Mechanism Of Action And Functions Of The Gli-related Proteins Glis 1-3
|
JETTEN, ANTON
|
NIH
|
|
$1,186,065
|
|
Polycystic Kidney Disease
|
NHGRI
|
1Z01HG000215-06
|
|
Human Biochemical Genetics
|
GAHL, WILLIAM
|
NIH
|
|
$4,516,035
|
|
Polycystic Kidney Disease
|
NHGRI
|
1Z01HG200348-01
|
|
NHGRI/DIR Cytogenetics and Microscopy Core
|
BIESECKER, LESLIE
|
NIH
|
|
$868,313
|
|
Polycystic Kidney Disease
|
NHLBI
|
1Z01HL005108-01
|
|
The Cell Biology of Polarized Cells
|
MILGRAM, SHARON
|
NIH
|
|
$921,690
|
